Article Information
- Received March 9, 2012
- Revision received May 14, 2012
- Accepted May 17, 2012
- First published July 4, 2012.
- Version of record published July 4, 2012.
Author Information
Author contributions
Author contributions: A.S.K., J.M.M., and H.L.F. designed research; A.S.K. and D.C.A. performed research; A.S.K. contributed unpublished reagents/analytic tools; A.S.K. and A.N.-C. analyzed data; A.S.K., J.M.M., and H.L.F. wrote the paper.
Disclosures
- Received March 9, 2012.
- Revision received May 14, 2012.
- Accepted May 17, 2012.
This work was supported by funding from the Wheeler Center for the Neurobiology of Addiction, Telemedicine and Advanced Technology Research Center Grants W81XWH-10-1-0231 and W81XWH-11-1-0596 (J.M.M., A.S.K., H.L.F.), Alcoholic Beverage Medical Research Foundation/The Foundation for Alcohol Research (A.S.K.), and funds from the State of California (H.L.F., A.S.K.). We thank Dawn Weinstein and Candice Teague for essential help with subject screening, and the subjects themselves for their participation.
The authors declare no competing financial interests.
- Correspondence should be addressed to Andrew S. Kayser, Department of Neurology, University of California, San Francisco, Ernest Gallo Clinic and Research Center, 5858 Horton Street, Suite 200, Emeryville, CA 94608. akayser{at}gallo.ucsf.edu
Online Impact